BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $85,554,000 | +208.3% | 565,941 | +197.2% | 0.01% | +200.0% |
| Q2 2022 | $27,748,000 | +128.2% | 190,433 | +85.7% | 0.00% | +100.0% |
| Q1 2022 | $12,158,000 | +6.8% | 102,552 | +24.2% | 0.00% | +100.0% |
| Q4 2021 | $11,383,000 | +93.5% | 82,603 | +95.0% | 0.00% | 0.0% |
| Q3 2021 | $5,883,000 | +12.9% | 42,358 | -21.1% | 0.00% | 0.0% |
| Q2 2021 | $5,210,000 | +85.4% | 53,669 | +30.6% | 0.00% | – |
| Q1 2021 | $2,810,000 | -76.9% | 41,109 | -71.0% | 0.00% | -100.0% |
| Q4 2020 | $12,143,000 | +268.6% | 141,665 | +179.7% | 0.00% | +100.0% |
| Q3 2020 | $3,294,000 | -44.7% | 50,647 | -37.8% | 0.00% | 0.0% |
| Q2 2020 | $5,956,000 | +206.7% | 81,466 | +42.8% | 0.00% | 0.0% |
| Q1 2020 | $1,942,000 | -52.9% | 57,056 | -24.6% | 0.00% | 0.0% |
| Q4 2019 | $4,119,000 | +31.7% | 75,661 | +0.9% | 0.00% | 0.0% |
| Q3 2019 | $3,128,000 | -23.9% | 74,980 | -20.1% | 0.00% | 0.0% |
| Q2 2019 | $4,110,000 | +0.7% | 93,862 | +18.3% | 0.00% | 0.0% |
| Q1 2019 | $4,082,000 | +136.2% | 79,323 | +69.8% | 0.00% | 0.0% |
| Q4 2018 | $1,728,000 | -55.0% | 46,706 | -54.4% | 0.00% | 0.0% |
| Q3 2018 | $3,843,000 | -60.2% | 102,354 | -58.1% | 0.00% | -66.7% |
| Q2 2018 | $9,656,000 | +366.9% | 244,350 | +204.3% | 0.00% | +200.0% |
| Q1 2018 | $2,068,000 | +146.5% | 80,296 | +158.0% | 0.00% | – |
| Q4 2017 | $839,000 | -16.7% | 31,117 | +15.5% | 0.00% | – |
| Q3 2017 | $1,007,000 | +248.4% | 26,944 | +133.0% | 0.00% | – |
| Q2 2017 | $289,000 | – | 11,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |